Dr. Sowmya Deshpande has disposed of a significant portion of her stake in Family Care Hospitals , selling 9,56,007 equity shares through the open market. The sales transactions occurred between August 7, 2026, and August 11, 2026. As a result of this disposal, her holding in the company decreased from 32,59,136 shares (6.03% of total voting capital) to 23,03,129 shares (4.26% of total voting capital).

The disclosure was submitted to the Bombay Stock Exchange Limited on August 11, 2026, in compliance with Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dr. Deshpande is not classified as part of the promoter or promoter group of the target company.

Transaction Details

The following table outlines the changes in shareholding before and after the sale:

There were no encumbrances, pledges, liens, or non-disposal undertakings on the shares held by Dr. Deshpande either before or after the transaction. Additionally, there were no voting rights held otherwise than by equity shares, nor were there any warrants or convertible securities involved in this holding.

Capital Structure Context

Family Care Hospitals Limited has an equity share capital of Rs. 54,01,47,740/-, comprising 5,40,14,774 shares with a face value of Rs.10 per share. The total diluted share/voting capital remains unchanged at Rs. 54,01,47,740/- following this transaction. The company’s scrip code on the BSE is 516110, and its ISIN is INE146N01016.

Family Care Hospitals Limited company name reported a narrowed standalone net loss of ₹42.37 lakh for the quarter ended June 30, 2026 (Q1FY27), compared to a loss of ₹69.52 lakh in the same period last year. The improvement was driven by a 190% year-on-year surge in revenue from operations, which rose to ₹5 lakh from ₹1.72 lakh in Q1FY26. Despite the revenue growth, the company continues to face significant headwinds, with statutory auditors flagging ₹38.03 crore in unutilised inventory that remains on the books pending shareholder approval for transfer.

The Board of Directors approved the unaudited financial results and the limited review report issued by Rafik and Associates, the company’s statutory auditors, on July 31, 2026. The meeting also saw the immediate appointment of Mr. Ashdullah Khan as Company Secretary and Compliance Officer. Mr. Khan is an Associate Member of the Institute of Company Secretaries of India with experience in Companies Act and Listing Regulations compliance.

Financial Performance

The company’s total income stood at ₹6.13 lakh in Q1FY27, up from ₹1.72 lakh in Q1FY26. This increase was primarily due to higher other income, which jumped to ₹1.13 lakh from nil in the corresponding prior period. However, total expenses remained high at ₹48.50 lakh, dominated by employee benefits expense of ₹9.72 lakh and depreciation and amortisation of ₹19.94 lakh. Finance costs were recorded at ₹6.44 lakh.

For the full fiscal year FY26, the company reported a net loss of ₹868.29 lakh against a total income of ₹45.02 lakh. Revenue from operations for the year was ₹20.97 lakh.

Auditor Concerns on Inventory

A critical aspect of the filing is the attention drawn by statutory auditors Rafik and Associates to Note No. 5 of the financial results. The note discloses ₹38.03 crore in discount coupon vouchers included under inventories. These vouchers have remained unutilised due to the closure of the company’s main hospital operations.

Management intends to transfer this stock to a related party; however, the requisite shareholder approval has not been received as of June 30, 2026. Consequently, the inventory continues to be carried at its book value. The auditors stated they are unable to comment on the realizable value of these vouchers or the appropriateness of carrying them at book value, citing the prolonged closure of operations and absence of a definitive revival timeframe.

What the Numbers Show

The divergence between the narrow operational revenue and the massive inventory carry-forward highlights the company’s transitional state. While the top-line revenue grew significantly on a low base, it remains negligible compared to the ₹38.03 crore in dormant assets. The reduction in net loss is largely attributable to a decrease in total expenses, particularly other expenses which swung from a negative balance in the prior quarter to a positive ₹8.38 lakh, rather than organic operational profitability. The persistence of high employee benefit costs (₹9.72 lakh) relative to minimal revenue suggests ongoing fixed cost burdens despite the closure of main hospital operations.